After almost five meaningful years at the @IcahnMountSinai, I’ll be wrapping up my time here at the end of June and closing this chapter of my academic career. I’m deeply grateful to my colleagues, trainees, collaborators, and leaders at Mount Sinai for the opportunities to build programs together and push the science of neuroimmunology and care of inflammatory skin (and other) disease forward — it has been a privilege to grow alongside such a talented community. In July, I’ll be joining the Feinstein Institutes for Medical Research & @NorthwellHealth as the inaugural Chief Biotechnology Officer, focusing on building new bridges between discovery, clinical research, and biotech across the health system. I’m excited about the chance to help accelerate translational science at scale and to work with new partners across academia, industry, and venture. My lab will continue to focus on foundational science in neuroimmunology. More details soon. To everyone I’ve had the chance to work with so far — thank you. I’m looking forward to staying in touch, finding new ways to collaborate, and continuing to advance the field together from this new perch.